ROLAKE OLUWASEUN ALABI
Allopathic & Osteopathic Physicians|Ophthalmology AUSTIN, TX NPI 1891290797
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology TX ABBVIE INC. All categories
General Payments — all program years on this page
$6,025.97
- Category: General Payments
- Program years: PY2021–2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,946.89 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,312.50 | 1 |
| Food and Beverage | $634.39 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,357.50 | 2 |
| Regeneron Pharmaceuticals, Inc. | $149.94 | 1 |
| Bausch & Lomb Americas Inc. | $118.01 | 1 |
| Apellis Pharmaceuticals, Inc. | $109.29 | 1 |
| Amgen Inc. | $107.67 | 1 |
| Genentech, Inc. | $83.12 | 2 |
| Genentech USA, Inc. | $21.36 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1103131265 | ABBVIE INC. | $1,312.50 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1103195462 | ABBVIE INC. | $45.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114395876 | Regeneron Pharmaceuticals, Inc. | $149.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115414518 | Amgen Inc. | $107.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133101160 | Genentech USA, Inc. | $21.36 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133101164 | Genentech, Inc. | $60.39 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133101168 | Genentech, Inc. | $22.73 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140437916 | Bausch & Lomb Americas Inc. | $118.01 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154028815 | Apellis Pharmaceuticals, Inc. | $109.29 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.